NEW YORK, —
According to a new report published by Arcview Market Research, retail cannabis sales will grow 33 percent to nearly $10 billion in 2017 and the legal cannabis market is expected to reach $24.5 billion by 2021, with a compound annual growth rate of 28 percent. The report indicated that medical cannabis market in California is already as big as the total markets of Colorado, Washington, and Oregon combined. In 2018, cannabis for recreational use has become legal in California, the world’s sixth largest economy. According to BDS Analytics, the cannabis market in California is expected to reach $5.1 billion in 2019. Global Payout, Inc. (OTC: GOHE), Surna Inc. (OTC: SRNA), Easton Pharmaceuticals, Inc. (OTC: EAPH), Cannabis Science, Inc. (OTC: CBIS), CV Sciences, Inc. (OTC: CVSI)
According to another report from Arcview Market Research, consumers in North America spent about $53 billion in the legal and illegal cannabis markets in 2016. “The enormous amount of existing, if illicit, consumer spending sets cannabis apart from most other major consumer-market investment opportunities throughout history,” said Troy Dayton, CEO of Arcview. Unlike most other industries throughout history, “the cannabis industry doesn’t need to create demand for a new product or innovation – it just needs to move demand for an already widely-popular product into legal channels.”
Global Payout, Inc. (OTC: GOHE) earlier today the company just announced that, “its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC” “MoneyTrac”, the “Company”) has executed a Sales and Marketing Management Agreement with High Grade Management Group, Inc. (“HGMG”) to guide the development and implementation of a sales and marketing campaign to support the successful launch of HGMG’s Apple Vapes products.”
Aiming to revolutionize and capture a significant share of the multi-million-dollar vape market space, HGMG has introduced Apple Vapes. This new line of products delivers innovative and high-quality vape pens, chargers, and oils to consumers and retailers in one of the fastest growing market spaces. In addition to providing MTRAC with a direct source of revenue through the retainer they will receive for sales and marketing services, the agreement also serves as reinforcement of MTRAC’s expanding business development service arm which is directed towards the growing number of businesses in the underserved cannabis industry.
MTRAC CEO, Vanessa Luna said: “This agreement is an excellent opportunity for MoneyTrac to play a strategic role in developing effective brand awareness for HGMG’s Apple Vapes product line. The support and expertise that I anticipate our business development team will be able to lend to HGMG will undoubtedly provide them with the invaluable tools and resources necessary to take full advantage of a rapidly expanding marketplace.”
Said HGMG CEO, Mark Glover: “As we look to capitalize on the multi-million-dollar vape industry, securing a partnership like this with MoneyTrac is absolutely vital in making sure we make a significant splash in this competitive market space as well as ensure that Apple Vapes is positioned to become a consistent revenue powerhouse by delivering the most innovative and top quality vape products to consumers and retailers in the industry.”
Surna Inc. (OTCQB: SRNA) develops innovative technologies and products that monitor, control and or address the energy and resource intensive nature of indoor cannabis cultivation. On November 14, 2017, the company announced operating and financial results for the three and nine months ended September 30, 2017. They will not be hosting a conference call following the release of our financial results. Revenue for the three months ended September 30, 2017was $1,566,000 compared to $1,171,000 for the three months ended September 30, 2016, an increase of $395,000, or 34%. Recent and anticipated regulatory changes involving medicinal and/or recreational cannabis use in various jurisdictions, such as California, tends to be a leading indicator for the granting of licenses for new facility construction. As more new cultivation facilities become licensed, the company have an expanded set of opportunities and customers to whom they can potentially sell their systems.
Easton Pharmaceuticals, Inc. (OTC: EAPH) is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. On October 20, 2017, the company announced its final payment which completes its $1.3 Million CDN JV agreement with Canadian based 1124123 Ontario Limited (o/a – Alliance Group) towards a 50% property ownership interest and various businesses including the cultivation of medical / recreational marijuana for national Canadian market. Pursuant to this closed agreement, Easton’s JV partner, Alliance Group (1124123 Ontario Limited) have been advised by its legal representation that it has cleared its last license exemption hurdles which clears a path for Alliance to grow, cultivate and distribute medical / recreational marijuana for the country of Canada. This has now resulted in Alliance Group bringing forward interim facility engineering plans with expectations of a completed greenhouse growing facility within 6 months which would be near the anticipated national launch date of recreational / medical marijuana for the country of Canada. Recreational marijuana has been made legal nationally in Canada and is expected to be launched in late spring of 2018 where many industry observers have estimated a huge shortage of marijuana product once launched.
Cannabis Science, Inc. (OTC: CBIS) takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. On December 28, 2017, the company announced that its expansion plans are progressing rapidly as the final negotiations have been completed for the third medical marijuana dispensary in California. The Company is preparing the final documents now to complete integration of its third medical marijuana operations for the California market opening.
CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. On November 14, 2017, the company announced it has been named on Deloitte’s Technology Fast 500™, an annual ranking of the fastest growing companies in the technology, media, telecommunications, life sciences and energy tech sectors in North America. The Deloitte Technology Fast 500 is based on percentage of revenue growth from fiscal year 2013 to 2016, with CV Sciences growing by 403% during this period.
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.